We use cookies for analytics and ads to improve your experience. You can accept or decline. See our Privacy Policy.
Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

Credit Rating (CRISIL)
CARE A
Rates the company's debt-servicing ability — not the quality or value of its shares.
Rated: 2 Dec 2025
View Full ReportValuation
Financials (FY2024)
Source: CRISILInvestment Thesis
Lakeshore Hospital and Research Centre Limited (VPS Lakeshore) is one of Kerala's most significant independent multi-specialty hospitals, with strong brand equity, comprehensive tertiary care capabilities, and the financial backing of VPS Healthcare Group under Dr. Shamsheer Vayalil. The hospital is well-positioned to benefit from Kerala's growing healthcare demand and its unique international patient pipeline from the Gulf. While the unlisted structure limits public financial visibility, the underlying healthcare business appears robust and growth-oriented.
Pros
Cons
Business Segments
Inpatient Services (IPD)
Tertiary and quaternary inpatient care across multiple specialties including cardiac surgery, oncology, transplantation, neurosciences, and orthopaedics. Revenue driven by bed occupancy, procedure mix, and payer profile.
Outpatient Services (OPD) & Diagnostics
High-volume outpatient consultations, diagnostic imaging (MRI, CT, PET scan), pathology, and day-care procedures. Critical for patient acquisition and funnel management into inpatient services.
International Patient / Medical Tourism
Services to NRI patients (particularly Gulf diaspora) and international medical tourists leveraging Kochi's airport connectivity and VPS Healthcare's UAE network.
Revenue Model
Lakeshore Hospital generates revenue primarily from inpatient surgical and medical procedures, outpatient consultations, and diagnostic services across its multi-specialty facilities. Revenue is driven by a mix of private pay, health insurance (Mediclaim, CGHS, state insurance schemes), and international patient payments. The VPS Healthcare Group's UAE network provides an additional pipeline of high-value international patients seeking tertiary care in India at cost-effective rates.
Detailed Analysis
Growth Plans
Growing NRI and international patient volumes from the Gulf diaspora leveraging VPS Healthcare's UAE network
Rising health insurance penetration in Kerala driving volumes and collections
Expansion of high-value specialties (organ transplant, oncology, robotics surgery) supporting ARPOB (Average Revenue Per Occupied Bed) growth
Potential future IPO or listing as VPS Healthcare Group's India portfolio matures
Industry Tailwinds
Recent Developments
VPS Lakeshore has been expanding its speciality care capacity in areas including oncology and cardiac care to meet growing demand from Kerala's NRI-linked patient population and domestic healthcare seekers.
2024-03The VPS Healthcare Group has publicly stated strategic intent to deepen its India healthcare presence, with Kerala hospitals including Lakeshore being a central pillar of this expansion strategy.
2023-09Comparable Companies
ASTERDM · ~₹16,000 Cr (listed)
Frequently Asked Questions
About Lakeshore Hospital and Research Centre Limited
Lakeshore Hospital and Research Centre Limited is a leading multi-super-speciality hospital in Kerala, incorporated in 1996 under CIN U85110KL1996PLC010260 and registered with the Registrar of Companies, Ernakulam. Branded as VPS Lakeshore Hospital, the facility is located along National Highway 66 at Nettoor, Kochi — making it one of the most accessible tertiary care hospitals in Kerala's commercial capital. The hospital operates a 470-bed facility offering comprehensive healthcare across 30+ clinical departments including cardiology, cardiac surgery, neurology, neurosurgery, orthopedics, oncology, gastroenterology, nephrology, urology, and transplant medicine. VPS Lakeshore is distinguished by its strong focus on organ transplantation — offering kidney, liver, heart, and corneal transplant programs — making it a referral destination from across Kerala and neighboring states. VPS Lakeshore is part of the VPS Healthcare group, one of the Middle East's largest private healthcare conglomerates, founded by Dr. V.P. Shamsheer. The group's international footprint provides access to global medical expertise, technology, and treatment protocols. This backing positions Lakeshore among Kerala's premium private hospital brands, competing with Aster Medcity and Amrita Hospital for complex and high-acuity cases. Revenue for FY2024-25 stood at approximately Rs. 416 crore, with operating revenue in the Rs. 100-500 crore range (FY2024). The hospital has been a beneficiary of growing medical tourism from Gulf NRI patients seeking quality affordable care in their home state, as well as domestic demand for advanced tertiary care in the Kochi catchment area. The board of directors includes Dr. V.P. Shamsheer (Chairman), S.K. Abdulla (Managing Director), K.N.P. Nair, Dr. K.V. Johny, P.D. Mathew, M.M. Mathai, Job Varghese, Dr. K. Chithrathara, Reuben George Joseph, and V. Venugopal. Company Secretary R. Muraleedharan handles compliance and governance functions.
Key Milestones
1996 — Incorporated as Lakeshore Hospital and Research Centre Limited in Kerala (CIN: U85110KL1996PLC010260)
Common questions about unlisted shares
You buy from and sell to the wisefolio desk — shares route through the desk's demat, money-in before shares-out.
You enquire
· Takes 2 minutesTell us the company and quantity you want. Share your demat details so we can settle directly into your account.
We source & quote
· Typically within 1 business dayOur desk sources the shares and comes back with a firm price and an allocation for the quantity available.
You accept the allocation
· Quote valid for 3 daysReview the price, quantity and total. Accept to lock the allocation. The quote is valid for a short window before it needs re-pricing.
You transfer the funds
· Pay within 2 days of acceptingPay by direct bank transfer to the desk's published account — never to a personal account. We confirm receipt and begin the transfer.
Shares reach your demat
· Usually credited within 2–3 business daysOnce payment is verified, the shares are transferred from the desk's demat into yours, and you receive a transfer confirmation.
A principal desk for unlisted & pre-IPO shares — you transact with us, not a stranger.
You enquire
Takes 2 minutes
We source & quote
Typically within 1 business day
You accept the allocation
Quote valid for 3 days
You transfer the funds
Pay within 2 days of accepting
Shares reach your demat
Usually credited within 2–3 business days
Unlisted shares are illiquid and carry higher risk. Pricing is indicative, not live, and these are private off-market transactions with no exchange settlement guarantee. Read the full risk disclosure.
Be the first to discuss Lakeshore Hospital and Research Centre Limited — share your research, ask questions, or compare notes with other investors.
Growing NRI and international patient volumes from the Gulf diaspora leveraging VPS Healthcare's UAE network
Rising health insurance penetration in Kerala driving volumes and collections
Expansion of high-value specialties (organ transplant, oncology, robotics surgery) supporting ARPOB (Average Revenue Per Occupied Bed) growth
Potential future IPO or listing as VPS Healthcare Group's India portfolio matures
Industry Headwinds
Intensifying competition from Aster DM Healthcare and other expanding hospital chains in Kochi
Government price regulation under health schemes compressing margins on a portion of patient mix
Dependence on specialist doctors who may have individual mobility constraints
Key Strengths
Well-established and experienced promoter group in healthcare industry
Reputed and experienced team of doctors
Diversified revenue stream across specialities
Healthy capital structure and debt protection metrics
Key Weaknesses
Moderate occupancy levels
Dependence on scarce qualified medical professionals
Geographical concentration of revenue and growing competition in the industry
Downward Factors
Large debt-funded capital expenditure, leading to moderate capital structure with gearing ratio above 0.7x
Aster DM Healthcare (listed), Amrita Institute of Medical Sciences, and Rajagiri Hospital are direct competitors in Kochi's tertiary care market with strong speciality and brand positioning.
Source: AlphaHub Research
Kerala's Clinical Establishments Act and healthcare pricing regulations can cap procedural fees, potentially limiting revenue upside. Government health schemes (PMJAY/Karunya) impose price discipline on participating hospitals.
Source: Company Financial Filings
Specialist doctors and senior nursing staff are in high demand across Kerala, Gulf countries, and international markets; attrition or inability to attract top specialists directly impacts clinical quality and revenue.
Source: AlphaHub Research
Hospitals require continuous re-investment in medical equipment, technology upgrades, and infrastructure maintenance; any capital constraints can affect clinical capabilities and competitiveness.
Source: Regulatory Filings
Unlisted status means investors in shares have no access to audited financials, making it impossible to verify debt levels, profitability, or asset quality from public sources.
Source: Media Reports / Public Records
Moderate occupancy levels
Source: AlphaHub Research
Dependence on scarce qualified medical professionals
Source: Media Reports / Public Records
Geographical concentration of revenue and growing competition in the industry
Source: Company Financial Filings
Aster DM Healthcare (listed), Amrita Institute of Medical Sciences, and Rajagiri Hospital are direct competitors in Kochi's tertiary care market with strong speciality and brand positioning.
Kerala's Clinical Establishments Act and healthcare pricing regulations can cap procedural fees, potentially limiting revenue upside. Government health schemes (PMJAY/Karunya) impose price discipline on participating hospitals.
Specialist doctors and senior nursing staff are in high demand across Kerala, Gulf countries, and international markets; attrition or inability to attract top specialists directly impacts clinical quality and revenue.
Hospitals require continuous re-investment in medical equipment, technology upgrades, and infrastructure maintenance; any capital constraints can affect clinical capabilities and competitiveness.
Unlisted status means investors in shares have no access to audited financials, making it impossible to verify debt levels, profitability, or asset quality from public sources.
APOLLOHOSP · ~₹90,000 Cr (listed)
FORTIS · ~₹35,000 Cr (listed)
Established as a multi-specialty hospital in Kochi, Kerala's commercial and medical hub
Acquired by / integrated into VPS Healthcare Group under Dr. Shamsheer Vayalil, expanding the group's India presence complementing its UAE hospital network
Developed into one of Kerala's premier tertiary care referral centres with advanced cardiac, oncology, and transplant programmes
Continues to operate as unlisted entity as of 2025, with VPS Healthcare managing operations under the VPS Lakeshore brand